Skip to content

Setup accuracy of tattoo-Less surface-guided breast radiotherapy with regional nodal irradiation: SPOTLESS

Setup accuracy of tattoo-Less surface-guided breast radiotherapy with regional nodal irradiation: SPOTLESS

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038990
Enrollment
30
Registered
2026-01-14
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer, radiation therapy, tattoo-free surface-guided radiation

Interventions

Group 1: Patient positioning and the planning CT scan will be performed non-study specific in supine position with arms raised above the head with standard Wingstep® immobilization device. Patients un
only the tattoo-free positioning procedure constitutes a study-related intervention. All other aspects of treatment are consistent with standard clinical practice.

Sponsors

Universitätsklinikum Heidelberg, Radiologische Klinik, RadioOnkologie und Strahlentherapie
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Patients with an indication for image-guided, postoperative photon radiotherapy of the breast or chest wall with regional nodal irradiation -ECOG Performance status = 2 -ability of subject to understand character and individual consequences of the clinical trial -written informed consent

Exclusion criteria

Exclusion criteria: -pregnant or lactating women -comorbidities or anatomical reasons that prevent a standard positioning in Wingstep® immobilization device

Design outcomes

Primary

MeasureTime frame
The primary endpoint (binary, acceptable criteria reached yes/no) is based on the proportion of treatment fractions meeting the predefined acceptable setup accuracy criteria. Technical practicability for an acceptable setup accuracy will be concluded, if =90% of treatment fractions meet the predefined criteria of residual setup deviation =6 mm in all translational directions following precise surface-guided alignment, as verified by daily cone-beam CT (CBCT).

Secondary

MeasureTime frame
For secondary objectives, including setup time evaluation, data will be reported descriptively (mean with standard deviation or median with interquartile range or absolute and relative frequencies) and repeated-measures ANOVA for patient-reported outcome using numeric rating scales.

Countries

Germany

Contacts

Public ContactEva Meixner

Universitätsklinikum Heidelberg, Radiologische Klinik, RadioOnkologie und Strahlentherapie

eva.meixner@med.uni-heidelberg.de+49 (0)6221 56 -311110

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026